🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is conducted in order to find out if repeated doses of the monocl...
Status
Completed
Location
Study Site
Start Date
2010-12
Trial ID
NCT01481493
The goal of the study is to investigate the safety, tolerability and effica...
Status
Recruiting
Location
Save Sight Institute
Start Date
2025-08-29
Trial ID
NCT06628947
Treatments Being Tested
The primary objective of the study was to investigate the safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00224783
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2017-07-11
Trial ID
NCT03191383
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested
Phase I study aiming at: * establishing the pharmacokinetic profile of int...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02517788
This study is limited to conduct in China only. The primary objective is to...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-07-28
Trial ID
NCT05387070
Treatments Being Tested
A randomized, double-blind, placebo-controlled phase I clinical study evalu...
Status
Not Yet Recruiting
Location
Huashan Hospital
Start Date
2025-04
Trial ID
NCT06945445
A single center, double-blind, randomized, dose-escalation study to assess ...
Status
Completed
Location
Taipei Medical University
Start Date
2019-03-26
Trial ID
NCT04088721
Treatments Being Tested
The SUBMO-PIC01-2025 study evaluates whether SUBMO®, a submucosal injection...
Status
Recruiting
Location
Hospital Universitario de la Santa Creu i Sant Pau
Start Date
2026-04-29
Trial ID
NCT07448129
Treatments Being Tested